Clinical guideline
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesDeveloped in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons

https://doi.org/10.1016/j.jtcvs.2011.10.019Get rights and content
Under a Creative Commons license
open access

Cited by (0)

This document was approved by the American College of Cardiology Foundation Board of Trustees and the American Heart Association Science Advisory and Coordinating Committee in April 2011. The American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons approved the document in June 2011.

The American Association for Thoracic Surgery requests that this document be cited as follows: Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2011;142:1303–38.

This article is copublished in the Journal of the American College of Cardiology and Circulation.

Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.cardiosource.org) and the American Heart Association (my.americanheart.org). For copies of this document, please contact Elsevier Inc. Reprint Department, fax (212) 633-3820; E-mail, [email protected].

Expert peer review of AHA Scientific Statements is conducted at the AHA National Center. For more on AHA statements and guidelines development, visit http://my.americanheart.org/statements and select the “Policies and Development” link.

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of The American Association for Thoracic Surgery. Please contact Elsevier’s permission department at [email protected].

Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for detailed information.

ACCF/AHA Representative.

ACCF/AHA Task Force on Performance Measures Liaison.

§

Society of Thoracic Surgeons Representative.

American Association for Thoracic Surgery Representative.

Heart Rhythm Society Representative.

#

Society for Cardiovascular Angiography and Interventions Representative.

**

American Society of Echocardiography Representative.

††

Pediatric Content Expert.

‡‡

Heart Failure Society of America Representative.

§§

American Society of Nuclear Cardiology Representative.

‖‖

ACCF/AHA Task Force on Practice Guidelines Liaison.

¶¶

Former Task Force member during this writing effort.